🔎 Trials Near Me

Почетна › Рак дојке › Luizijana › New Orleans

Kliničke studije za Рак дојке u gradu New Orleans, LA

11 studija za Рак дојке traži učesnike na lokacijama u gradu New Orleans i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Тражи се учесникФаза 1
  • Ochsner Medical Center (OMC), New Orleans
Узраст од 18 до 55 · Жене · Ажурирано 12. 11. 2026. · NCT07310420

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Тражи се учесникФаза 3
  • Ochsner Clinic Foundation ( Site 0021), New Orleans
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06966700

E-Mindfulness Approaches for Living After Breast Cancer

Тражи се учесникФаза 3
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • West Jefferson Medical Center, Marrero · 4 ми удаљено
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
  • и још 1
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3
  • University Medical Center New Orleans, New Orleans
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Тражи се учесникФаза 3
  • Care Access-Marrero, Marrero · 4 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Тражи се учесникФаза 1/2
  • Louisiana State University Health Sciences Center, New Orleans
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT05768139

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, New Orleans
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

CtDNA Based MRD Testing for NAC Monitoring in TNBC

Тражи се учесникОпсервациона студија
  • Louisiana State University, New Orleans
Узраст 18 и старији · Жене · Ажурирано 7. 1. 2025. · NCT06230185

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu New Orleans

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.